Skip to main content
SpringerLink
Log in

Serum soluble interleukin 2 receptor levels in patients with breast cancer

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Preoperative levels of serum soluble interleukin-2 receptor (IL-2R) were examined in 37 patients with breast cancer. We investigated the correlations of serum soluble IL-2R levels with various factors such as stage grouping, lymph node metastasis, distant metastasis, tumor size, histopathological type, estrogen receptor (ER), progesterone receptor (PgR) and CA 153. Serum soluble IL-2R levels were measured with an enzyme-linked immunosorbent assay.

Levels of serum soluble IL-2R in the patients with stage III and IV breast cancer were significantly higher than those in the normal controls, and patients with stage I and II breast cancer. Preoperative levels of serum soluble IL-2R in patients with T3 and T4 were also significantly higher than those in patients with T1 and T2. Serum levels of IL-2R in patients with distant metastasis were also significantly higher than those in patients without distant metastasis. Moreover, serum levels of soluble IL-2R in patients with higher CA 15-3 were significantly higher than those in patients with normal CA 15-3 levels.

We conclude that preoperative serum soluble IL-2R levels in patients with breast cancer may be a valuable parameter, especially in evaluating whether they have distant metastasis or not.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

IL-2R:

Interleukin-2 receptor

ER:

Estrogen receptor

PgR:

Progesterone receptor

References

  1. Smith KA: Interleukin-2; Inception, impact, and implications.Science 240:1169–1176, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Berg JW, Hutter RVP: Breast cancer.Cancer 75:257–269, 1995.

    Article  PubMed  CAS  Google Scholar 

  3. Hayes DF, Sekine H, Ohno T,et al: Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.J Clin Invest 75:1671–1678, 1985.

    Article  PubMed  CAS  Google Scholar 

  4. Hermanek P, Sobin LH eds: International Union Against Cancer; TNM Classification of Malignant Tumuors, 4th ed, Springer-Verlag, Germany, pp 43–46, 1992.

    Google Scholar 

  5. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording for Breast Cancer, 10th ed, Kanehara Shuppan, Tokyo, pp19–20, 1985.

    Google Scholar 

  6. Rubin LA, Kurman CC, Fritz ME,et al: Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro.J Immunol 135:3172–3177, 1985.

    PubMed  CAS  Google Scholar 

  7. Rovelli F, Lissoni P, Crispino S,et al: Increased level of soluble interleukin-2 receptor in advanced solid tumors.Tumori 74:633–637, 1988.

    PubMed  CAS  Google Scholar 

  8. Lissoni P, Barni S, Rovelli F,et al: The biological significance of soluble interleukin-2 receptor in solid tumors.Eur J Cancer 26:33–36, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Marino P, Cugno M, Preatoni A,et al: Increased levels of soluble interleukin-2 receptors in serum of patients cancer.Br J Cancer 61:434–435, 1990.

    PubMed  CAS  Google Scholar 

  10. Yamaguchi K, Nishimura Y, Kiyokawa T,et al: Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.J Lab Clin Med 116:457–461, 1990.

    PubMed  CAS  Google Scholar 

  11. Pavlidis NS, Manoussakis MN, Germanidis GS,et al: Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.Med Pediatric Oncol 20:26–31, 1992.

    Article  CAS  Google Scholar 

  12. Ginns LS, Hoyos AD, Brown MC,et al: Elevated smokers concentration of soluble interleukin-2 receptors in serum of patients with lung cancer.Am Rev Respir Dis 142:398–402, 1990.

    PubMed  CAS  Google Scholar 

  13. Honda M, Kitamura K, Matsuda K,et al: Soluble IL- 2 receptors in AIDS.J Immunol 142:4248–4255, 1989.

    PubMed  CAS  Google Scholar 

  14. Prummel MF, Wiersinga WM, Van Der Gaag R,et al: Soluble IL-2 receptor levels in patients with Graves’ ophthalmopathy.Clin Exp Immunol 88:405–409, 1992.

    Article  PubMed  CAS  Google Scholar 

  15. Pui CH, Ip SH, Iflah S,et al: Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia.Blood 71:1135–1137, 1988.

    PubMed  CAS  Google Scholar 

  16. Symons JA, Wood NC, Di Giovine FS,et al: Soluble IL-2 receptor in rheumatoid arthritis.J Immunol 141: 2612–2618, 1988.

    PubMed  CAS  Google Scholar 

  17. Tisi E, Lissoni P, Angeli M,et al: Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma.Cancer 69:2458–2462, 1992.

    Article  PubMed  CAS  Google Scholar 

  18. Keicho N, Kitamura K, Takaku F,et al: Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis.Chest 98:1125–1129, 1990.

    Article  PubMed  CAS  Google Scholar 

  19. Brown AE, Rieder KT, Wehster HK: Prolonged elevation of soluble interleukin-2 receptors in tuberculosis.Am Rev Respir Dis 139:1036–1038, 1989.

    PubMed  CAS  Google Scholar 

  20. Murakami S, Satomi A, Ishida K,et al: Serum soluble interleukin-2 receptor in colorectal cancer.Acta Oncol 33:19–21, 1994.

    Article  PubMed  CAS  Google Scholar 

  21. Murakami S, Satomi A, Ishida K,et al: Serum soluble interleukin-2 receptor concentrations in patients with gastric cancer.Cancer 74:2745–2748, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Gotteland MG, May E, Levin FM,et al: Estrogen receptor (ER) in human breast cancer.Cancer 74:864–871, 1994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Saitama Medical School, 38 Morohongo, Moroyamamachi, Iruma-gun, 350-04, Saitama, Japan

    Saburo Murakami, Rennzo Hirayama, Akira Satomi, Katsuhiko Okubo, Moriyoki Matsuki, Hideto Sakata & Yoshitaka Tsuji

Authors
  1. Saburo Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rennzo Hirayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Satomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katsuhiko Okubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Moriyoki Matsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideto Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshitaka Tsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Murakami, S., Hirayama, R., Satomi, A. et al. Serum soluble interleukin 2 receptor levels in patients with breast cancer. Breast Cancer 4, 25–28 (1997). https://doi.org/10.1007/BF02967051

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967051

Key words

Search

Navigation